Besim Ogretmen

28PUBLICATIONS
120CO-AUTHORS
Predictive and prognostic markersCell development, proliferation and deathApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Energy generation, conversion and storage (excl. chemical and electrical)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Jul 15, 2026
Tumor and Stromal Sphingolipid Imbalance Are Associated with T Cell Tissue Residency in Glioblastoma.

|Jul 06, 2026
Proteomic analysis of sphingolipid metabolic enzymes with risk of bladder cancer incidence and mortality in the Atherosclerosis Risk in Communities (ARIC) Study.

|Jun 12, 2026
Proteome Responses to Acute Inhibition of De Novo Sphingolipid Synthesis Suggest Cancer Combination Therapies.

|Jun 02, 2026
Sphingosine kinase-2 inhibition promotes immunogenic differentiation of myeloid-derived suppressor cells through an Acetyl-CoA carboxylase-phosphatidylcholine axis.

|Mar 27, 2026
Palmitate-induced mitochondrial damage restricts histone acetylation in CD8 T cells to impair antitumor immunity.

Silvia Tiberti, Sara Gennari, Martina Romeo

|Jan 06, 2026
Sphingolipid signaling links elastin deficiency to arterial hyper-muscularization and congenital heart disease.

Odai Darawshi, Besim Ogretmen

Pageof 5

Frequent Collaborators

7 joint publications

Mohamed Faisal Kassir

6 joint publications

Natalia V Oleinik

4 joint publications

Shikhar Mehrotra

3 joint publications

Alhaji H Janneh